ArticleBMC genomics2018

MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.

Weijing Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.